Gujarat Inject Kerala Announces Rs 3 Crore Preferential Warrant Issue

3,00,00,000 equity warrants to be issued to 11 public investors; authorized share capital to rise by Rs 2.63 crore.

Reader Takeaway: The capital injection aims to boost liquidity, though shareholders face potential dilution pending upcoming EGM approval.

What just happened

Gujarat Inject Kerala Ltd held a board meeting on October 29, 2026, where directors cleared a proposal to issue 3 crore equity warrants to a group of 11 non-promoter investors. Each warrant, with a face value of Rs 1, is convertible into one equity share within 18 months from the date of allotment. The issue price will be set as per SEBI (ICDR) regulations.

Why this matters

The fundraising is intended to bring in fresh capital for the company. To accommodate the issuance and future capital needs, the board has proposed an increase in the authorized share capital from Rs 15,00,00,000 to Rs 17,63,48,000. This shift requires formal backing from shareholders via an Extraordinary General Meeting (EGM).

Key Investors

The preferential issue is directed toward non-promoter entities, with the largest allocation going to JV Investment, a partnership firm, which is set to receive 1.90 crore warrants. Other investors include individuals like Ramchandra Dallaram Choudhary, Ankit Jain, and various HUF entities, confirming a broad participation from the public category.

What to track next

Investors should look for the notice of the EGM, where shareholders will vote on the proposed capital hike and warrant issuance. Regulatory and statutory filings regarding the final pricing of the warrants remain the next key event to monitor for shareholders and market participants.